Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

NCT06411171 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Junction Cancer

Interventions

DRUG: Pembrolizumab plus chemotherapy (FLOT)

Sponsor

xiaohua li